PDL BioPharma Seeks Ularitide Partner That Grants Rights To A Late-Stage Drug
A more complicated partnership involving two clinical programs is taking more time to complete than a “ularitide-only” deal, the biotech says.
A more complicated partnership involving two clinical programs is taking more time to complete than a “ularitide-only” deal, the biotech says.